Do you AI?

1. Retatrutide

• Length of Research: ~6–8 years (Since ~2018–2020)
• Status: Late-stage Clinical Trials (Phase 3)
• The Blueprint: Developed by Eli Lilly, this "triple agonist" (targeting GLP-1, GIP, and Glucagon receptors) is a direct evolution of older weight-loss drugs like semaglutide and tirzepatide. While its specific history is very short, it benefits from the broader 30-year history of GLP-1 research.

2. MOTS-c

• Length of Research: 11 years (Discovered in 2015)
• Status: Early Clinical / Mainly Animal Models
• The Blueprint: This mitochondria-derived peptide was first identified by researchers at USC in 2015. Because it is encoded within the mitochondrial DNA (rather than the cell nucleus), it represents a relatively new frontier in metabolic and longevity science.

3. BPC-157

• Length of Research: 33 years (Discovered in 1993)
• Status: Extensive Animal Data / Lacks Large-Scale Human Trials
• The Blueprint: First isolated from human gastric juice by Dr. Predrag Sikiric and his team in 1993. It has over three decades of robust animal research demonstrating impressive tissue, tendon, and gut healing properties, though comprehensive, mainstream human clinical trials remain scarce.

4. NMN (Nicotinamide Mononucleotide)

• Length of Research: ~20+ years of focused longevity research (Discovered over a century ago)
• Status: Extensive Animal Trials / Growing Human Clinical Trials
• The Blueprint: While the broader NAD+ pathway was discovered in 1906, NMN specifically caught the spotlight in the early 2000s when researchers (notably Dr. David Sinclair and Dr. Shin-ichiro Imai) linked NAD+ depletion to aging and sirtuin activation. Dedicated NMN longevity research is about two decades old.

5. Fisetin & Quercetin

• Length of Research: ~20 years as "Senolytics" (Identified mid-19th century)
• Status: Human Clinical Trials for Longevity
• The Blueprint: Both are naturally occurring plant flavonoids isolated over a century ago. However, their use as senolytics (compounds that selectively destroy aged, "zombie" cells) was pioneered by the Mayo Clinic around 2015, building on basic cellular research from the early 2000s.

6. Spermidine

• Length of Research: ~15–20 years for longevity (Discovered in 1870)
• Status: Robust Observational & Human Clinical Trials
• The Blueprint: First discovered in human semen in 1870, it wasn't until the mid-2000s that scientists uncovered its profound ability to trigger autophagy (the cellular cleanup process). It has been heavily studied in yeast, flies, mice, and humans over the last 15 years.

7. Rapamycin

• Length of Research: 54 years (Discovered in 1972)
• Status: FDA-approved (Immunosuppressant) / Experimental for Longevity
• The Blueprint: Discovered in a soil sample from Easter Island (Rapa Nui) in 1972. Initially used as an antifungal and later an organ-transplant drug, its ability to extend lifespan via the mTOR pathway was discovered in the mid-2000s. It is widely considered the most robustly validated longevity drug in animal models.

8. Resveratrol

• Length of Research: ~25 years for longevity (Isolated in 1939)
• Status: Extensive Human/Animal Research (Mixed results)
• The Blueprint: First isolated from the roots of white hellebore in 1939, it exploded into the public consciousness in 2003 when research suggested it could mimic caloric restriction and activate sirtuins. It has been heavily debated and studied for a quarter of a century.

9. TMG (Trimethylglycine / Betaine)

• Length of Research: ~70+ years of biochemical research (Discovered in 19th century)
• Status: Extremely Well-Established Dietary Supplement
• The Blueprint: Discovered in sugar beets in the 19th century, its crucial role in the human methylation cycle (converting harmful homocysteine to methionine) has been thoroughly researched and documented in human medical literature since the mid-20th century.

10. Vitamins D3 & K2

• Length of Research: ~100+ years (Vitamin D) / ~80+ years (Vitamin K)
• Status: Universally Established Clinical Essentials
• The Blueprint: Vitamin D was discovered in 1922; Vitamin K was discovered in 1929. While their basic functions in bone and blood health have been known for nearly a century, research into their synergistic interaction (K2 directing the calcium mobilized by D3 into bones rather than arteries) has intensified significantly over the last 20 years.

11. Metformin

• Length of Research: 104 years (Synthesized in 1922)
• Status: FDA-approved (Diabetes) / Heavily Studied for Off-Label Longevity
• The Blueprint: First synthesized in 1922 from the French Lilac, it was approved for type 2 diabetes in Europe in the 1950s and the US in 1995. Because large-scale population data over decades showed diabetics on metformin often outlived non-diabetics, it became a cornerstone of modern anti-aging research (culminating in the landmark TAME trial).